Trial Profile
A Multicenter Randomized Study to Compare the Safety and Efficacy of Low-dose Versus Standard Dose Lopinavir/Ritonavir Containing HAART Regimen in Virological Suppressed HIV-infected Thai Children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2024
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PEARL
- 03 Jul 2013 Substudy results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 03 Jul 2013 Status changed from active, no longer recruiting to completed, based on resuts presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 03 Jul 2013 Results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.